This site is intended for healthcare professionals
News

Recovery in hospitalized patients with COVID-19 in NIAID-sponsored ACTT-2 trial of baricitinib plus remdesivir.

Read time: 1 mins
Last updated:15th Sep 2020
Published:15th Sep 2020
Condition: Coronavirus/COVID-19 Infection
Type: drug
Register free for full access to medthority.com